(Saint-lgnace-de-Stanbridge, Quebec) May 28th, 2022 – FORUS was a proud sponsor and participant in the Défi Cyclo-Myélome.  This is the 10th year of this important event which aims to increase awareness about multiple myeloma and raise funds for the Myeloma Canada...

(TORONTO, Ontario) May 2-3, 2022 ­– FORUS Therapeutics Inc, a Canadian Life Sciences company specialized in developing and commercializing unique and differentiated oncology focused therapies is proud to be participating and presenting at the 2022 Bloom Burton &...

(OAKVILLE, Ontario) February 22, 2022 ­– FORUS Therapeutics, a Canadian biopharmaceutical company dedicated to advancing differentiated, novel medicines for hematologic malignancies and other forms of cancer, today announced it has secured $2.5M CAD in growth capital...

FORUS Therapeutics is delighted to introduce Marie-Josèphe Champagne as the Senior Medical Science Liaison for Québec and Atlantic Canada.  Marie-Josèphe has over 18 years of experience in the pharmaceutical industry in commercial and medical affairs roles, primarily...

Despite all the global and local challenges; related and unrelated to the pandemic, 2021 has been a year of tremendous growth, progress and development at FORUS. We are excited about 2022 and look forward to fulfilling our mission by bringing innovative new medicines...

In recognition of this last day of September and the close of Blood Cancer Awareness Month, FORUS Therapeutics Inc. is pleased to announce that Health Canada has accepted for review the New Drug Submission (NDS) for once-weekly XPOVIO® (selinexor) in combination with...

FORUS Therapeutics is excited to introduce Kim Newhouse as the Senior Medical Manager. Recognized as a dedicated medical affairs business partner with a drive to deliver with excellence, Kim brings two decades of hematology/oncology launch experience in the Canadian...

We are thrilled to introduce Tracy Nagy as the Senior Medical Science Liaison for Central Canada. Tracy has dedicated her over 35-year career to patients in hematology/oncology including extensive experience as a MSL and as a Nurse Practitioner/Transplant Coordinator...

FORUS Therapeutics is delighted to introduce Deirdre Hay as the Senior Medical Science Liaison for Western Canada. Deirdre has extensive experience in both commercial and medical affairs roles in hematology and oncology, with the last 10 years as a MSL focused on...

We are very pleased to announce that Alison Vanlerberghe has joined the FORUS Therapeutics team as our Market Access Lead. An industry recognized leader in Market Access, Alison brings a wealth of experience and partnership success, having formed multi-stakeholder...

FORUS Therapeutics is pleased to introduce Tom Kowalik as Senior Manager, Commercial Operations and Insights. Tom joins FORUS bringing a wealth of operational and analytical capabilities that will be critical as FORUS establishes the needed knowledge, systems and...

FORUS Therapeutics is pleased to welcome Chris Blowes as Associate Director, Regulatory Affairs. Chris is a highly experienced pharmaceutical industry professional who has supported development and commercial teams throughout numerous product life cycles. Most...